• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

产前使用吲哚美辛作为宫缩抑制剂:对新生儿肾功能的影响。

Prenatal administration of indomethacin as a tocolytic agent: effect on neonatal renal function.

作者信息

Wurtzel D

机构信息

Division of Neonatology, Albert Einstein Medical Center, Philadelphia, Pennsylvania.

出版信息

Obstet Gynecol. 1990 Oct;76(4):689-92.

PMID:2216206
Abstract

Renal function was evaluated in premature infants whose mothers received long-term indomethacin for tocolysis. Creatinine, urine and serum osmolalities, fractional excretion of sodium, and glomerular filtration rate were compared during the first 10 postnatal days in 14 preterm infants exposed to indomethacin in utero and in ten control infants. Renal function in both groups was comparable, with no significant differences on any study date in serum urea nitrogen and creatinine, ratio of urine osmolality to serum osmolality, fractional excretion of sodium, or glomerular filtration rate. These data suggest that long-term intrauterine administration of indomethacin does not significantly alter renal function.

摘要

对母亲因保胎而长期使用吲哚美辛的早产儿的肾功能进行了评估。比较了14名在子宫内接触过吲哚美辛的早产儿和10名对照婴儿出生后前10天内的肌酐、尿和血清渗透压、钠排泄分数以及肾小球滤过率。两组的肾功能相当,在任何研究日期,血清尿素氮和肌酐、尿渗透压与血清渗透压之比、钠排泄分数或肾小球滤过率均无显著差异。这些数据表明,长期宫内给予吲哚美辛不会显著改变肾功能。

相似文献

1
Prenatal administration of indomethacin as a tocolytic agent: effect on neonatal renal function.产前使用吲哚美辛作为宫缩抑制剂:对新生儿肾功能的影响。
Obstet Gynecol. 1990 Oct;76(4):689-92.
2
Risk of persistent renal insufficiency in premature infants following the prenatal use of indomethacin for suppression of preterm labor.产前使用吲哚美辛抑制早产对早产儿持续性肾功能不全的风险。
J Perinatol. 2002 Oct-Nov;22(7):541-6. doi: 10.1038/sj.jp.7210790.
3
The effects of indomethacin tocolysis on the postnatal response of the ductus arteriosus to indomethacin in extremely low birth weight infants.吲哚美辛抑制宫缩对极低出生体重儿动脉导管产后对吲哚美辛反应的影响。
J Perinatol. 2007 Jan;27(1):22-7. doi: 10.1038/sj.jp.7211612. Epub 2006 Oct 19.
4
Intravenous indomethacin and changes of renal function in premature infants with patent ductus arteriosus.静脉注射吲哚美辛与动脉导管未闭早产儿肾功能的变化
Pediatr Pharmacol (New York). 1984;4(1):11-9.
5
Indomethacin and its effect on renal function and urinary kallikrein excretion in premature infants with patent ductus arteriosus.
Pediatrics. 1981 Jul;68(1):99-102.
6
Furosemide does not prevent indomethacin-induced renal side effects in preterm infants.呋塞米不能预防吲哚美辛引起的早产儿肾脏副作用。
Clin Pharmacol Ther. 1997 Aug;62(2):181-6. doi: 10.1016/S0009-9236(97)90066-7.
7
Prenatal maternal indomethacin use resulting in prolonged neonatal renal insufficiency.产前母亲使用吲哚美辛导致新生儿肾功能不全持续时间延长。
J Perinatol. 1993 Nov-Dec;13(6):425-7.
8
Efficacy of aggressive tocolysis for preterm labor with advanced cervical dilatation.积极的宫缩抑制疗法对宫颈扩张进展的早产的疗效。
J Matern Fetal Neonatal Med. 2005 Jul;18(1):47-52. doi: 10.1080/14767050500073142.
9
Maternal renal impairment after indomethacin tocolysis.吲哚美辛保胎治疗后出现的母体肾功能损害。
J Perinatol. 1993 Nov-Dec;13(6):461-3.
10
Efficacy and safety of indomethacin versus ritodrine in the management of preterm labor: a randomized study.吲哚美辛与利托君治疗早产的疗效及安全性:一项随机研究
Obstet Gynecol. 1989 Oct;74(4):567-72.

引用本文的文献

1
Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants.预防性静脉注射吲哚美辛预防早产儿死亡和发病
Cochrane Database Syst Rev. 2010 Jul 7;2010(7):CD000174. doi: 10.1002/14651858.CD000174.pub2.
2
Metaanalysis of the effect of antenatal indomethacin on neonatal outcomes.产前使用吲哚美辛对新生儿结局影响的荟萃分析。
Am J Obstet Gynecol. 2007 Nov;197(5):486.e1-10. doi: 10.1016/j.ajog.2007.04.019.
3
Nonsteroidal anti-inflammatory agents in neonates.新生儿使用的非甾体抗炎药。
Paediatr Drugs. 2003;5(6):385-405. doi: 10.2165/00128072-200305060-00004.
4
NSAID-induced nephrotoxicity from the fetus to the child.从胎儿到儿童的非甾体抗炎药诱导的肾毒性。
Drug Saf. 2001 Jan;24(1):9-18. doi: 10.2165/00002018-200124010-00002.
5
Treatment of inflammatory rheumatic disorders in pregnancy: what are the safest treatment options?妊娠期炎性风湿性疾病的治疗:最安全的治疗选择有哪些?
Drug Saf. 1998 Nov;19(5):389-410. doi: 10.2165/00002018-199819050-00006.
6
Optimisation of antirheumatic drug treatment in pregnancy.孕期抗风湿药物治疗的优化
Clin Pharmacokinet. 1994 Dec;27(6):486-503. doi: 10.2165/00003088-199427060-00006.